Skip to search formSkip to main contentSkip to account menu

desloratadine

Known as: 8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine, desloratadine [Chemical/Ingredient], 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine 
A long-acting piperidine derivate with selective H1 antihistaminergic and non-sedating properties. Desloratadine diminishes the typical histaminergic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Background:  Desloratadine is associated with decreased signs and symptoms and improved nasal airflow in multiple clinical trials… 
Highly Cited
2006
Highly Cited
2006
ABSTRACT Objective: To assess the efficacy and onset of action of azelastine nasal spray and desloratadine tablets in patients… 
2006
2006
Background Second‐generation antihistamines are H1 receptor antagonists and may have additional anti‐inflammatory effects. 
Review
2004
Review
2004
Background Allergic rhinitis (AR) is associated with robust infiltration of immune cells and mediators that may contribute to… 
2004
2004
Background There are no data directly comparing the relative efficacy of modern H1‐antihistamines in allergic rhinitis using… 
2003
2003
INTRODUCTION The purpose of this study was to establish whether the H1-antihistamine desloratadine (5 mg), the active metabolite… 
Highly Cited
2001
Highly Cited
2001
Nefazodone inhibits CYP3A; therefore coadministration with CYP3A substrates such as terfenadine or loratadine may result in…